Health care providers and their patients jointly participate in melanoma prevention, surveillance, diagnosis, and treatment. This paper reviews screening and follow-up strategies for patients who have been diagnosed with melanoma, based on current available evidence, and focuses on methods to assess disease recurrence and second primary occurrence. Secondary prevention, including the roles of behavioral modification and chemoprevention are also reviewed. The role of follow-up dermatologist consultation, with focused physical examinations complemented by dermatoscopy, reflectance confocal microscopy, and/or full-body mapping is discussed. Furthermore, we address the inclusion of routine imaging and laboratory assessment as components of foll...
Early diagnosis of melanoma leads to the best prognosis for patients and may be more likely achieved...
52 7.2 Souhrn v anglickém jazyce Malignant melanoma is the most lethal skin cancer whose incidence h...
Background: A history of cutaneous malignancies puts patients at an increased risk of developing add...
Introduction: Follow-up guidelines for melanoma greatly differ in the methods of screening for recur...
Follow-up services for patients with localised cutaneous melanoma are widely discussed but there is ...
The primary goal of follow-up examinations in cutaneous melanoma is to detect development of second ...
BACKGROUND: Patients treated for melanoma are advised to have lifelong full body skin examinations....
Background: The value of follow-up surveillance for patients with cutaneous melanoma remains uncerta...
Background: The value of follow-up surveillance for patients with cutaneous melanoma remains uncerta...
BACKGROUND: Most subsequent new primary or recurrent melanomas might be self-detected if patients ar...
Background: Research on patient follow-up compliance after a diagnosis of melanoma has been limited....
With a rising incidence of melanoma worldwide, the number of patients in clinical follow-up will kee...
Post-treatment follow-up for patients with American Joint Committee on Cancer (AJCC) stage I/II mela...
The aim of followup programs for patients diagnosed with melanoma is early detection of local, regio...
Abstract Background Patients may decide to undertake shared care with a general practitioner (GP) du...
Early diagnosis of melanoma leads to the best prognosis for patients and may be more likely achieved...
52 7.2 Souhrn v anglickém jazyce Malignant melanoma is the most lethal skin cancer whose incidence h...
Background: A history of cutaneous malignancies puts patients at an increased risk of developing add...
Introduction: Follow-up guidelines for melanoma greatly differ in the methods of screening for recur...
Follow-up services for patients with localised cutaneous melanoma are widely discussed but there is ...
The primary goal of follow-up examinations in cutaneous melanoma is to detect development of second ...
BACKGROUND: Patients treated for melanoma are advised to have lifelong full body skin examinations....
Background: The value of follow-up surveillance for patients with cutaneous melanoma remains uncerta...
Background: The value of follow-up surveillance for patients with cutaneous melanoma remains uncerta...
BACKGROUND: Most subsequent new primary or recurrent melanomas might be self-detected if patients ar...
Background: Research on patient follow-up compliance after a diagnosis of melanoma has been limited....
With a rising incidence of melanoma worldwide, the number of patients in clinical follow-up will kee...
Post-treatment follow-up for patients with American Joint Committee on Cancer (AJCC) stage I/II mela...
The aim of followup programs for patients diagnosed with melanoma is early detection of local, regio...
Abstract Background Patients may decide to undertake shared care with a general practitioner (GP) du...
Early diagnosis of melanoma leads to the best prognosis for patients and may be more likely achieved...
52 7.2 Souhrn v anglickém jazyce Malignant melanoma is the most lethal skin cancer whose incidence h...
Background: A history of cutaneous malignancies puts patients at an increased risk of developing add...